No insider purchase over the last 90 days. The latest was filed 05 Jun 2026.
Ventas, Inc., classified in the Real Estate sector, is a listed company based in Chicago, United States, founded in 1998. Its insiders report their share dealings to SEC (Form 4). 18 insiders have disclosed 97 filings since 18 October 2025.
The record shows 1 purchase on the open market worth €170k, made by 1 insider, against 5 sales worth €5.0M by 3 insiders. Netting one side against the other leaves €4.8M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 1 senior executive among the declarants. The largest single trade was a sale of €2.5M by Roberts Carey S., published on 13 February 2026.
The last insider purchase was made public on 5 June 2026, 135 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Compared with its exchange (5,813 companies, median 19 filings), a count of 97 filings is above the norm. The full history, which starts in 2016, counts 1 purchase against 22 sales. The 10-K for the year ended 31 December 2025 shows 5.83 bn USD of revenue and 261.5 m USD of net income and a dividend of 1.92 USD per share.
Other companies in the same sector with recent insider buying flagged by our signals: Agree Realty Corp and Simon Property Group Inc /DE/. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Ventas, Inc. Buy (bullish), based on 22 analysts. Average price target: US$100.86.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 551 declarations
Ventas, Inc. (NYSE: VTR) is a United States-listed healthcare real estate investment trust and an S&P 500 constituent. Headquartered in Chicago, Illinois, the company was founded in 1983 and has evolved into one of the best-known owners of healthcare- and aging-related real estate in North America. Its portfolio spans senior housing communities, outpatient medical buildings, research centers, and specialized facilities where critical care is delivered. Ventas reports through three operating segments: SHOP (senior housing operating portfolio), OM&R (outpatient medical and research), and NNN (triple-net leased properties). ([s203.q4cdn.com](https://s203.q4cdn.com/581756553/files/doc_financials/2025/q4/Ventas-Reports_2025_Fourth_Quarter_Results.pdf))
From a strategic standpoint, Ventas is built around secular demographic demand. The company emphasizes the aging population in the United States, the need for more senior housing, and the growing demand for outpatient care and medical research infrastructure. Its business model combines direct ownership, operator partnerships, and long-term lease structures, allowing the company to target both operational upside and income durability. Ventas also highlights its data-driven Ventas OITM platform and its strong capital base as differentiating tools for portfolio management and capital allocation. ([s203.q4cdn.com](https://s203.q4cdn.com/581756553/files/doc_financials/2025/q4/Ventas-Reports_2025_Fourth_Quarter_Results.pdf))
Ventas is not a traditional healthcare operator; it is primarily a real estate owner and capital provider. In SHOP, it owns senior housing communities and engages third-party operators to run them. In OM&R, it primarily acquires, owns, develops, leases, and manages outpatient medical buildings and research centers. In NNN, it owns healthcare facilities such as senior housing, skilled nursing facilities, long-term acute care facilities, inpatient rehabilitation facilities, and other specialized assets under triple-net or absolute-net leases. That mix gives the company exposure to multiple parts of the healthcare real estate value chain while keeping the core thesis centered on aging-related demand. ([app.edgar.tools](https://app.edgar.tools/companies/VTR/disclosures/segments?utm_source=openai))
Competitive positioning remains strong. Ventas describes itself as one of the largest owners of senior housing, with a broad portfolio across the United States, Canada, and the United Kingdom. Recent company disclosures also point to a portfolio of roughly 1,409 properties at year-end 2025, underscoring its scale. For investors in France, Belgium, and Switzerland, that combination of scale, recurring rental exposure, and demographic tailwinds makes Ventas a notable healthcare REIT rather than a pure real estate play. ([s203.q4cdn.com](https://s203.q4cdn.com/581756553/files/doc_financials/2025/q4/Ventas-Reports_2025_Fourth_Quarter_Results.pdf))
Recent developments have reinforced the growth narrative. In 2025, Ventas acquired 52 senior housing communities for $2.3 billion, and in January and February 2026 it acquired another 26 senior housing communities for $842.2 million. The company also entered 2026 with improved leverage metrics and announced a quarterly dividend of $0.52 per share in May 2026. Taken together, these updates suggest a management team leaning into external growth while maintaining a disciplined balance sheet and a clear focus on senior housing, its largest and fastest-moving engine. ([s203.q4cdn.com](https://s203.q4cdn.com/581756553/files/doc_financials/2025/ar/2025_VTR_AnnualReport.pdf))
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 22 filings published between 4 August and 15 October 2026: no open-market purchase or sale filed by an insider. 22 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 16 October 2026 (UTC)
Headquarters: Chicago, United States · Founded: 1998 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Dec 2025 | 5.83 bn USD | 261.5 m USD | 0.54 USD | 1.92 USD | 10-K |
| Dec 2024 | 4.92 bn USD | 88.4 m USD | 0.19 USD | 1.80 USD | 10-K |
| Dec 2023 | 4.50 bn USD | -30.3 m USD | -0.10 USD | 1.80 USD | 10-K |
| Dec 2022 | 4.13 bn USD | -40.9 m USD | -0.12 USD | 1.80 USD | 10-K |
| Dec 2021 | 3.83 bn USD | 56.6 m USD | 0.13 USD | 1.80 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.